Variant report
Variant | esv2760182 |
---|---|
Chromosome Location | chr11:104922670-104931988 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs562704 | chr11:104922670-104922671 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs533797847 | chr11:104922701-104922702 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs185471505 | chr11:104922712-104922713 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs78144702 | chr11:104922715-104922716 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs137869631 | chr11:104922728-104922729 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs12276590 | chr11:104922775-104922776 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs78278859 | chr11:104922803-104922804 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs578537 | chr11:104922809-104922810 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs554674367 | chr11:104922811-104922812 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs546059804 | chr11:104922847-104922848 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs1699073 | chr11:104922910-104922911 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
12 | rs35995863 | chr11:104922925-104922926 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs371094060 | chr11:104923031-104923032 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs1785882 | chr11:104923075-104923076 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs581153 | chr11:104923086-104923087 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs188795270 | chr11:104923156-104923157 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs192883737 | chr11:104923249-104923250 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs531568940 | chr11:104923255-104923256 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs548381360 | chr11:104923305-104923306 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs561810636 | chr11:104923308-104923309 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs527368922 | chr11:104923309-104923310 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs547133381 | chr11:104923321-104923322 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs79041817 | chr11:104923336-104923337 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs74756131 | chr11:104923338-104923339 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs377226048 | chr11:104923340-104923341 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs570427690 | chr11:104923348-104923349 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs539031052 | chr11:104923349-104923350 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs370039076 | chr11:104923350-104923351 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs569187584 | chr11:104923358-104923359 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs568371263 | chr11:104923521-104923522 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs538099166 | chr11:104923551-104923552 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs554734089 | chr11:104923563-104923564 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs185068135 | chr11:104923616-104923617 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs534304112 | chr11:104923624-104923625 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs78421830 | chr11:104923688-104923689 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs115403243 | chr11:104923699-104923700 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs532391 | chr11:104923706-104923707 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs562797177 | chr11:104923710-104923711 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs576401063 | chr11:104923720-104923721 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs542083290 | chr11:104923730-104923731 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs143739623 | chr11:104923768-104923769 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs188356431 | chr11:104923783-104923784 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs558435985 | chr11:104923814-104923815 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs79399172 | chr11:104923842-104923843 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs147205843 | chr11:104923873-104923874 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs549365305 | chr11:104923894-104923895 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs569251786 | chr11:104923907-104923908 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs191309905 | chr11:104923917-104923918 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs576411991 | chr11:104923934-104923935 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs508760 | chr11:104923951-104923952 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17603634 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Melanoma | 17363583 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Prostate cancer | 16573809 | CNVD |
Obesity | 19966786 | CNVD |
Prostate cancer | 18632612 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:104916800-104924400 | Weak transcription | Left Ventricle | heart |
2 | chr11:104918200-104925200 | Weak transcription | Ovary | ovary |
3 | chr11:104921400-104924600 | Enhancers | HepG2 | liver |
4 | chr11:104922200-104923400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
5 | chr11:104923200-104923800 | Enhancers | Dnd41 | blood |
6 | chr11:104924400-104924600 | Enhancers | Left Ventricle | heart |
7 | chr11:104924600-104927000 | Weak transcription | HepG2 | liver |
8 | chr11:104925600-104926400 | Enhancers | Primary monocytes fromperipheralblood | blood |
9 | chr11:104926400-104931600 | Weak transcription | Primary T regulatory cells fromperipheralblood | blood |
10 | chr11:104927000-104929200 | Enhancers | HepG2 | liver |
11 | chr11:104927000-104936200 | Weak transcription | Small Intestine | intestine |
12 | chr11:104928400-104928800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
13 | chr11:104929200-104930200 | Weak transcription | HepG2 | liver |
14 | chr11:104931000-104931200 | Enhancers | HepG2 | liver |
15 | chr11:104931000-104936800 | Weak transcription | Primary T helper cells fromperipheralblood | blood |
16 | chr11:104931600-104936200 | Strong transcription | Primary T regulatory cells fromperipheralblood | blood |